Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.

ABSTRACT:

Introduction

IgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as choice of treatment regimen. In this study, we investigated the long term survival of IgAN patients in our center and the factors affecting it.

Methods

This study included all biopsy-proven IgAN patients with ≥ 1year follow-up. Patients with diabetes mellitus at diagnosis and secondary IgAN were excluded. Medical records were reviewed for demographics, clinical presentation, blood pressure, 24-hour urine protein, serum creatinine, renal biopsy and treatment received. The primary outcome was defined as combined event of 50% estimated glomerular filtration rate (eGFR) reduction or ESRD.

Results<

SUBMITTER: Mohd R 

PROVIDER: S-EPMC8031432 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature